These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 26165801)

  • 1. [Preliminary guidelines of the Brazilian Society of Rheumatology for evaluation and treatment of tuberculosis latent infection in patients with rheumatoid arthritis, in face of unavailability of the tuberculin skin test].
    da Mota LM; Cruz BA; de Albuquerque CP; Gonçalves D; Laurindo IM; Pereira IA; de Carvalho JF; Pinheiro Gda R; Bertolo MB; da Silva NA; Louzada Júnior P; Xavier RM; Giorgi RD; Lima RA
    Rev Bras Reumatol; 2015; 55(4):390-3. PubMed ID: 26165801
    [No Abstract]   [Full Text] [Related]  

  • 2. Poor agreement between QuantiFERON-TB Gold test and tuberculin skin test results for the diagnosis of latent tuberculosis infection in rheumatoid arthritis patients and healthy controls.
    Lee JH; Sohn HS; Chun JH; Kim HA; Suh CH; Lee YW; Yoon BY
    Korean J Intern Med; 2014 Jan; 29(1):76-84. PubMed ID: 24574836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of a commercial interferon-gamma release assay and tuberculin skin test for the detection of latent tuberculosis infection in Hong Kong arthritis patients who are candidates for biologic agents.
    So H; Yuen CS; Yip RM
    Hong Kong Med J; 2017 Jun; 23(3):246-50. PubMed ID: 28126971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased detection of latent tuberculosis by tuberculin skin test and booster phenomenon in early rheumatoid arthritis patients.
    Pérez-Barbosa L; Esquivel-Valerio JA; Arana-Guajardo AC; Vega-Morales D; Riega-Torres J; Garza-Elizondo MA
    Rheumatol Int; 2015 Sep; 35(9):1555-9. PubMed ID: 25773658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prednisolone treatment affects the performance of the QuantiFERON gold in-tube test and the tuberculin skin test in patients with autoimmune disorders screened for latent tuberculosis infection.
    Bélard E; Semb S; Ruhwald M; Werlinrud AM; Soborg B; Jensen FK; Thomsen H; Brylov A; Hetland ML; Nordgaard-Lassen I; Ravn P
    Inflamm Bowel Dis; 2011 Nov; 17(11):2340-9. PubMed ID: 21319275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis of latent tuberculosis infection (LTBI) before anti-TNF-alpha treatment--the tuberculin skin test is useful.
    Goujon C; Nosbaum A; Bensaid B; Rozières A; Nicolas JF; Bérard F
    Eur J Dermatol; 2012; 22(5):701-2. PubMed ID: 23032063
    [No Abstract]   [Full Text] [Related]  

  • 7. The conversion rate of tuberculosis screening tests during biological therapies in patients with rheumatoid arthritis.
    Cuomo G; D’Abrosca V; Iacono D; Pantano I
    Clin Rheumatol; 2017 Feb; 36(2):457-461. PubMed ID: 27817127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of an interferon gamma assay in the diagnosis of latent tuberculosis infection in patients with rheumatoid arthritis.
    Marques CD; Duarte ÂL; de Lorena VM; Souza JR; Souza WV; Gomes Yde M; de Carvalho EM
    Rheumatol Int; 2009 Nov; 30(1):57-62. PubMed ID: 19363612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interferon-gamma release assays versus tuberculin skin testing in patients with rheumatoid arthritis.
    Song GG; Bae SC; Lee YH
    Int J Rheum Dis; 2013 Jun; 16(3):279-83. PubMed ID: 23981748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of latent tuberculosis infection screening strategies before tumor necrosis factor inhibitor treatment in inflammatory arthritis: IGRA-alone versus combination of TST and IGRA.
    Jeong DH; Kang J; Jung YJ; Yoo B; Lee CK; Kim YG; Hong S; Shim TS; Jo KW
    PLoS One; 2018; 13(7):e0198756. PubMed ID: 29975703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of replacing tuberculin skin test with ex vivo interferon γ release assays on decision to administer prophylactic antituberculosis antibiotics before anti-TNF therapy.
    Mariette X; Baron G; Tubach F; Lioté F; Combe B; Miceli-Richard C; Flipo RM; Goupille P; Allez M; Salmon D; Emilie D; Carcelain G; Ravaud P
    Ann Rheum Dis; 2012 Nov; 71(11):1783-90. PubMed ID: 22258485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Latent tuberculosis in rheumatoid arthritis: evaluating cellular response and high-resolution computed tomography.
    Tannus Silva DG; Silva BD; Torres PP; Santana PJ; Junqueira-Kipnis AP; Rabahi MF
    Arch Bronconeumol; 2012 May; 48(5):144-9. PubMed ID: 22401741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interferon-γ release assays or tuberculin skin test for detection and management of latent tuberculosis infection: a systematic review and meta-analysis.
    Zhou G; Luo Q; Luo S; Teng Z; Ji Z; Yang J; Wang F; Wen S; Ding Z; Li L; Chen T; Abi ME; Jian M; Luo L; Liu A; Bao F
    Lancet Infect Dis; 2020 Dec; 20(12):1457-1469. PubMed ID: 32673595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening of tuberculosis by interferon-gamma assay before biologic therapy for rheumatoid arthritis.
    Murakami S; Takeno M; Kirino Y; Kobayashi M; Watanabe R; Kudo M; Ihata A; Ueda A; Ohno S; Watanuki Y; Kaneko T; Ishigatsubo Y
    Tuberculosis (Edinb); 2009 Mar; 89(2):136-41. PubMed ID: 19211305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interferon-γ release assay versus tuberculin skin test prior to treatment with golimumab, a human anti-tumor necrosis factor antibody, in patients with rheumatoid arthritis, psoriatic arthritis, or ankylosing spondylitis.
    Hsia EC; Schluger N; Cush JJ; Chaisson RE; Matteson EL; Xu S; Beutler A; Doyle MK; Hsu B; Rahman MU
    Arthritis Rheum; 2012 Jul; 64(7):2068-77. PubMed ID: 22238071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Agreement between Quantiferon-TB gold test and tuberculin skin test in the identification of latent tuberculosis infection in patients with rheumatoid arthritis and ankylosing spondylitis.
    Inanc N; Aydin SZ; Karakurt S; Atagunduz P; Yavuz S; Direskeneli H
    J Rheumatol; 2009 Dec; 36(12):2675-81. PubMed ID: 19918035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The prevalence of latent tuberculosis infection in patients with inflammatory arthritis and the diagnostic efficacy of different screening methods].
    Liu YJ; Xu J; Guo Q; Li J; Sun YJ; Shi LJ
    Zhonghua Yi Xue Za Zhi; 2019 Jan; 99(1):20-24. PubMed ID: 30641659
    [No Abstract]   [Full Text] [Related]  

  • 18. Usefulness and limitations of QuantiFERON-TB Gold in Japanese rheumatoid arthritis patients: proposal to decrease the lower cutoff level for assessing latent tuberculosis infection.
    Maeda T; Banno S; Maeda S; Naniwa T; Hayami Y; Watanabe M; Itoh R; Sato S; Ueda R
    Mod Rheumatol; 2010 Feb; 20(1):18-23. PubMed ID: 19779763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can ELISpot replace the tuberculin skin test for latent tuberculosis?
    Greveson K
    Br J Nurs; 2009 Nov 12-25; 18(20):1248-54. PubMed ID: 20081663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Are the recommendations on tuberculosis screening still valid? Interferon gamma release assay (IGRA) and/or tuberculin skin test for diagnosis of latent tuberculosis infection (LTBI)].
    Ernst D; Witte T; Schmidt RE; Meyer-Olson D
    Z Rheumatol; 2013 Nov; 72(9):846-50. PubMed ID: 23942562
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.